Cite
HARVARD Citation
Passero, F. et al. (2016). The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. Expert review of anticancer therapy. 16 (7), pp. 697-703. [Online].